We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for PF-07321332 and ritonavir (Pfizer Australia Pty Ltd)
Active ingredients
PF-07321332 and ritonavir
Sponsor
Date of review outcome
Lapse date
Type
Provisional approval
Indication
For the treatment of adult patients with symptomatic, confirmed coronavirus infection
Therapeutic area
Infectious diseases